Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC Filing
Key Points Sold all 3,185,000 shares of Immunome, estimated at $37.30 million based on quarterly average pricing Quarter-end position value decreased by $37.30 million, reflecting both stock price movement and the sale Represents a 4.92% decrease in Opaleye Management’s 13F reportable assets under management Post-trade, Opaleye Management holds zero shares and zero dollar value in […]









